Kilitch Drugs (India) Market Value
KILITCH Stock | 310.05 3.95 1.29% |
Symbol | Kilitch |
Kilitch Drugs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kilitch Drugs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kilitch Drugs.
10/29/2023 |
| 11/22/2024 |
If you would invest 0.00 in Kilitch Drugs on October 29, 2023 and sell it all today you would earn a total of 0.00 from holding Kilitch Drugs Limited or generate 0.0% return on investment in Kilitch Drugs over 390 days. Kilitch Drugs is related to or competes with Tata Communications, Pritish Nandy, Entero Healthcare, Blue Jet, Medplus Health, Apollo Hospitals, and Sakar Healthcare. Kilitch Drugs is entity of India. It is traded as Stock on NSE exchange. More
Kilitch Drugs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kilitch Drugs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kilitch Drugs Limited upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.08) | |||
Maximum Drawdown | 17.1 | |||
Value At Risk | (3.53) | |||
Potential Upside | 4.08 |
Kilitch Drugs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kilitch Drugs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kilitch Drugs' standard deviation. In reality, there are many statistical measures that can use Kilitch Drugs historical prices to predict the future Kilitch Drugs' volatility.Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.09) | |||
Total Risk Alpha | (0.46) | |||
Treynor Ratio | 0.685 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kilitch Drugs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kilitch Drugs Limited Backtested Returns
Kilitch Drugs Limited has Sharpe Ratio of -0.0423, which conveys that the firm had a -0.0423% return per unit of risk over the last 3 months. Kilitch Drugs exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kilitch Drugs' Standard Deviation of 2.68, risk adjusted performance of (0.02), and Mean Deviation of 1.69 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.15, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Kilitch Drugs are expected to decrease at a much lower rate. During the bear market, Kilitch Drugs is likely to outperform the market. At this point, Kilitch Drugs Limited has a negative expected return of -0.12%. Please make sure to verify Kilitch Drugs' potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Kilitch Drugs Limited performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.14 |
Insignificant predictability
Kilitch Drugs Limited has insignificant predictability. Overlapping area represents the amount of predictability between Kilitch Drugs time series from 29th of October 2023 to 11th of May 2024 and 11th of May 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kilitch Drugs Limited price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Kilitch Drugs price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.14 | |
Spearman Rank Test | -0.24 | |
Residual Average | 0.0 | |
Price Variance | 368.34 |
Kilitch Drugs Limited lagged returns against current returns
Autocorrelation, which is Kilitch Drugs stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kilitch Drugs' stock expected returns. We can calculate the autocorrelation of Kilitch Drugs returns to help us make a trade decision. For example, suppose you find that Kilitch Drugs has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Kilitch Drugs regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kilitch Drugs stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kilitch Drugs stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kilitch Drugs stock over time.
Current vs Lagged Prices |
Timeline |
Kilitch Drugs Lagged Returns
When evaluating Kilitch Drugs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kilitch Drugs stock have on its future price. Kilitch Drugs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kilitch Drugs autocorrelation shows the relationship between Kilitch Drugs stock current value and its past values and can show if there is a momentum factor associated with investing in Kilitch Drugs Limited.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Kilitch Stock
Kilitch Drugs financial ratios help investors to determine whether Kilitch Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kilitch with respect to the benefits of owning Kilitch Drugs security.